Literature DB >> 6364844

Recovery of proximal tubular function from ischemic injury.

P A Johnston, H Rennke, N G Levinsky.   

Abstract

Fluid (sodium) reabsorption, total glucose efflux, and reabsorption of angiotensin II and insulin from the proximal convoluted tubule were studied in rats by in vivo microperfusion. After 35 min of total renal artery occlusion, function was assessed at two intervals, 0-1 h (early recovery, ER) and 2-4 h (late recovery, LR). Light and electron microscopic evaluation showed 60-75% loss of proximal convoluted tubule brush border membrane in ER and nearly complete restoration of brush border in LR. No other structural abnormalities were evident. Renal blood flow was unchanged from control during both ER and LR. During ER, fluid reabsorption was reduced to 29.8 +/- 5.2%, and total glucose efflux, at normal tubule loads, to 73.9 +/- 5.5% of control. However, angiotensin II and insulin reabsorption were unchanged. In LR, fluid reabsorption remained significantly reduced at 54.3 +/- 8.1% of control. Total glucose efflux from the proximal tubule was normal in LR at glucose loads of up to 400 pmol X min-1, but was significantly reduced at higher loads. Passive glucose efflux, measured in the presence of 10(-4)M phloridzin, was not altered by ischemia. Brief ischemia results in significant alterations in proximal tubular reabsorption of sodium and glucose, which correlate with a substantial loss of brush border during ER. However, despite restoration of cell morphology to normal in LR, transport defects for both sodium and glucose persist.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6364844     DOI: 10.1152/ajprenal.1984.246.2.F159

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  15 in total

1.  Evolution of renal function and Na+, K +-ATPase expression during ischaemia-reperfusion injury in rat kidney.

Authors:  Sara M Molinas; Laura Trumper; Esteban Serra; M Mónica Elías
Journal:  Mol Cell Biochem       Date:  2006-05-13       Impact factor: 3.396

2.  Characterization of ischemia-induced loss of epithelial polarity.

Authors:  B A Molitoris; C A Hoilien; R Dahl; D J Ahnen; P D Wilson; J Kim
Journal:  J Membr Biol       Date:  1988-12       Impact factor: 1.843

3.  Mechanisms whereby exogenous adenine nucleotides improve rabbit renal proximal function during and after anoxia.

Authors:  L J Mandel; T Takano; S P Soltoff; S Murdaugh
Journal:  J Clin Invest       Date:  1988-04       Impact factor: 14.808

Review 4.  Tubular Transport in Acute Kidney Injury: Relevance for Diagnosis, Prognosis and Intervention.

Authors:  Volker Vallon
Journal:  Nephron       Date:  2016-05-31       Impact factor: 2.847

5.  Ischemia induces partial loss of surface membrane polarity and accumulation of putative calcium ionophores.

Authors:  B A Molitoris; P D Wilson; R W Schrier; F R Simon
Journal:  J Clin Invest       Date:  1985-12       Impact factor: 14.808

6.  Ischemia induces surface membrane dysfunction. Mechanism of altered Na+-dependent glucose transport.

Authors:  B A Molitoris; R Kinne
Journal:  J Clin Invest       Date:  1987-09       Impact factor: 14.808

7.  Exogenous adenosine triphosphate (ATP) preserves proximal tubule microfilament structure and function in vivo in a maleic acid model of ATP depletion.

Authors:  P S Kellerman
Journal:  J Clin Invest       Date:  1993-10       Impact factor: 14.808

Review 8.  Renal metabolism and acute renal failure.

Authors:  K G Dickman; W R Jacobs; L J Mandel
Journal:  Pediatr Nephrol       Date:  1987-07       Impact factor: 3.714

9.  Gene knockout of the Na+-glucose cotransporter SGLT2 in a murine model of acute kidney injury induced by ischemia-reperfusion.

Authors:  Josselin Nespoux; Rohit Patel; Haiyan Zhang; Winnie Huang; Brent Freeman; Paul W Sanders; Young Chul Kim; Volker Vallon
Journal:  Am J Physiol Renal Physiol       Date:  2020-03-02

Review 10.  Glucose transporters in the kidney in health and disease.

Authors:  Volker Vallon
Journal:  Pflugers Arch       Date:  2020-03-06       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.